DownloadManaging Proton Pump Inhibitor Use in Older Adults Tool
Stay connected or get support
About the tool
Divided into four sections, the Managing Proton Pump Inhibitor Use in Older Adults Tool can help guide discussions and assessments with patients about the potential advantages and harms relating to PPI use among patients aged 65+. The tool outlines potential risks and benefits, steps to discontinuing use, ways to safely start and continue use, and alternatives to PPIs.
The Managing Proton Pump Inhibitor Use in Older Adults Tool was developed using the Centre for Effective Practice’s (CEP’s) integrated knowledge translation approach. This approach ensures that providers are engaged throughout the development processes through the application of user-centered design methodology. Clinical leadership of the resource was provided by Dr. Felicia Presenza. End users and clinical experts were also engaged to provide feedback.
The tool is one of several clinical tools developed as part of the Knowledge Translation in Primary Care Initiative. This multi-year initiative is a collaboration between the Centre for Effective Practice, Ontario College of Family Physicians (OCFP), and Nurse Practitioners’ Association of Ontario (NPAO). Funded by the Ministry of Health and Long-Term Care, this initiative supports primary care providers with the development of a series of clinical tools and health information resources. Learn more about the Knowledge Translation in Primary Care Initiative (KTinPC).
Dr. Felicia Presenza is a care of the elderly physician working in Sudbury, ON. She works at St. Joseph’s Continuing Care Centre on the rehab floor, and also provides dementia care at memory clinics. She has a geriatric-focused family practice and is faculty with The Review Course helping family medicine residents prepare for their CCFP exam.
Clinical Working Group
- Dr. Jane Cox, MD, CCFP
- Debora Steele, MScN, NP-PHC, CPMHNC(C), GNC(C)
- Katherine Trip, MN, NP
- Michael Schroder, MPH, RN(EC)
Thank you to all of our members for their work!
In addition to our clinical working group, we also sought input from target end users and other topic experts, including clinicians and patient representatives. We thank all individuals for their time and insights.